ClinicalTrials.Veeva

Menu

Proteome- and Methylation Profiles in Oropharyngeal Cancer (PROMEO)

A

Aalborg University Hospital

Status

Completed

Conditions

Oropharynx Cancer

Treatments

Diagnostic Test: Examination of saliva

Study type

Observational

Funder types

Other

Identifiers

NCT04567082
N-20200024

Details and patient eligibility

About

This clinical study aims to evaluate proteome- and methylation profiles in saliva in patients with oropharyngeal cancers

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Cancer group:

Inclusion Criteria:

  • Written informed consent
  • Verified oropharyngeal squamous cell carcinoma

Exclusion Criteria:

  • Other active cancer
  • Uncontrolled comorbidity
  • Unable to give informed consent

Control group:

Inclusion Criteria:

  • Written informed consent
  • Normal ENT examination

Exclusion Criteria:

  • Active cancer
  • Uncontrolled comorbidity
  • Unable to give informed consent

Trial design

45 participants in 2 patient groups

Cancer group
Treatment:
Diagnostic Test: Examination of saliva
Control group
Treatment:
Diagnostic Test: Examination of saliva

Trial contacts and locations

1

Loading...

Central trial contact

Christian Danstrup, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems